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ABSTRACT
The methods for healthcare reform are strikingly
underdeveloped, with much reliance on political power.
A methodology that combined methods from sources
such as clinical trials, experience-based wisdom, and
improvement science could be among the aims of the
upcoming work in the USA on comparative
effectiveness and on the agenda of the Center for
Medicare and Medicaid Innovation in the Centers for
Medicare and Medicaid Services. Those working in
quality improvement have an unusual opportunity
to generate substantial input into these processes
through professional organisations such as the
Academy for Healthcare Improvement and dominant
leadership organisations such as the Institute for
Healthcare Improvement.
CHALLENGE: MULTIPLE POORLY GOVERNED
METHODS FOR REFORM
The USA spends too much and gets too little
from its healthcare systemdthat is the
current dogma, and there is little reason to
doubt it. The logical follow-up is that the
nation needs to reform its service delivery
system, and that also is a readily justiﬁable
claim. Indeed, the nation has taken substan-
tial steps towards reforms in the recent
Patient Protection and Affordable Care Act
(PPACA).
1 However, the methods for reform
become less obvious as one sets out to ﬁll in
the details. The simple fact is that, other than
developing breakthroughs in diagnosis and
treatment of individuals or restructuring how
we pay for services, we have strikingly little
methodology of reform for medical care.
Exactly what do we aim to achieve, and
exactly how would we achieve it? I contend
that the answers that we offer for these two
key questions rely excessively on philosophies
of governance or philosophies of science,
and far too little on deliberately learning how
to accelerate the pace and guide the direc-
tion of improvements. I also contend that we
could develop the needed insights quickly, if
we set out to do so.
This paper explores some of the ideas and
strategies that would lead to a broader and
more integrated methodology for developing
the insights needed to guide improvements
inthedeliveryofhealthcareservices.Although
the examples are mostly from the USA, one
would expect that these methods and many of
the insights would be useful globally.
Mix of methods
Within the recollection of older researchers
and practitioners in medical care, society
celebrated medicine as an ‘art,’ and most of
its truths were distillations of experience
from seasoned practitioners. In the past half
century, the standard of proof in medical
care has moved strongly towards a scientiﬁc
model, seeking generalisable truths about
the workings of the body and of the inter-
ventions proposed. This has led to a useful
reiﬁcation of the randomised controlled trial,
with its ability to mask many effects of
unmeasured variables, secular trends and
random events; and the factual basis of
medical practice is much stronger than
accretion of experience by practitioners
could have achieved. This work has been
generally well supporteddby government,
academic institutions and businessesdand
many people make their living in medical
research governed by careful statistical proof.
However, the work has had its challenges.
Some issues are just too expensive to study
rigorously, some are too difﬁcult to measure
reliably, and some require so many exclu-
sions before sampling that the scope of
generalisability is uncertain or limited.
Furthermore, thoroughly inappropriate use
of human subjects in an array of medical
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The social determinants of actionresearch projects led to extensive review and regulation
aimed to prevent abuse.
Within the last 20 years, a complementary set of
process improvement methods has taken root, borrowed
from management of manufacturing. Continuous
quality improvement uses goal-setting, monitoring,
standardisation, testing and strategies for sustainability,
and spread in order to tackle potential dysfunctions in
service delivery, mostly within one organisation or
setting. The methods have often been successful in
rapidly and sustainably achieving better outcomes and
now form the backbone of major portions of profes-
sional and organisational credentialling. But the rela-
tionships between the methods of scientiﬁc research and
of quality improvement have not yet been worked out
well. For example, it not clear whether funding appro-
priated for ‘research’ could be used in ‘quality
improvement,’ whether improvement projects deserve to
be published or which ‘quality improvement’ projects
must undergo review under the regulations governing
‘research on human subjects’. Perhaps most importantly,
how to tackle important national priorities using
a prudent mix of methods has received scant attention.
Furthermore, as the recent US legislation
1 illustrates,
sometimes major changes (which may yield improve-
ments) arise from adoption of broad policies, such as
coverage of new categories of services by public insur-
ance, coverage of new beneﬁciaries or imposing perfor-
mance requirements for practitioners or insurance
companies. Those policies, of course, can also affect the
funding and other resources available for research or
quality improvement, and can dictate the resolution of
some points of uncertainty as to methods. But again,
how best to use public policy as part of the mix of
methods to achieve improvement is often left mostly to
power politics, informed only by scant information as to
the wise course to follow and constrained to be
‘permanent’ because of the overwhelming practical
difﬁculties in deliberately designing policy interventions
as tests that will be monitored and adjusted on the basis
of experience. So, when to use policy to achieve reforms
currently has no better evidence-based methodology at
its disposal (at least in the USA) than deciding how to
draw insights from sources like conventional medical
research and quality improvement. Other modes of
gaining insight and making improvement also play their
similarly happenstance rolesdfor example, epidemio-
logical surveillance, public health interventions outside
medical care (eg, housing, nutrition and environment)
and programme implementation with evaluation.
Politics as usual
Society has not developed a methodology to guide use of
the overall panoply of approaches that yield insights
useful to efﬁcient and effective reform. Instead, the
developmental process often leaves the setting of goals
and the implementation of methods to the political
arena. Perhaps enlightened, informed and fair political
agenda-setting is the best that complex democratic
society can do in setting goals, but evidence and wisdom
have strong roles to play in the selection of methods to
ensure that political priorities reﬂect reliable insights.
At present, however, the strong allegiance of many
powerful forces to the methods of orthodox medical
research serves to denigrate most other methods
of gaining insight. This is not merely an annoyance,
since it serves to make some kinds of insight unavailable
when costs, complexity or time pressures make conven-
tional medical research unavailable. Thus, rather
than relying on the experience of multiple sites in
improving a clinical process or drawing from the expe-
rience of multiple jurisdictions in relieving inequities,
leaders tend to discount those insights and thus
to abandon the possibility of thoughtful and
guided reform, either by not getting reforms under
way or leaving them to political forces operating with
inadequate information.
OPPORTUNITY: MIXED METHODS IN AN EXPERIENCE-BASED
METHODOLOGY
Every nation has strong reasons to move towards a highly
efﬁcient, highly reliable medical care system quickly.
Without that, healthcare costs will increasingly burden
the economy generally and unacceptably diminish resi-
dents’ opportunities. Some important steps are under
way in the USA already. The Patient Protection and
Affordable Care Act will bring ﬁnancial access to medical
services to almost all Americans, thus making the fate of
the delivery system more strongly constructed as a social
concern and less likely to be framed as subject to indi-
vidual merit or good fortune. That statute also sets up
a score of initiatives aiming for long-term improvement
in quality and efﬁciency, including a Center for Inno-
vation, funding for expanding quality improvement and
funding for comparative effectiveness research. Under
the American Recovery and Reinvestment Act,
2 The
Institute of Medicine reported a list of priorities for
comparative effectiveness research.
3
The ferment that the upcoming health reform will
generate could provide an important and unusual
opportunity to learn what we need to know about the
methods of managing complex healthcare systems. What
information can guide the work? What are the roles of
conventional medical research, of quality improvement,
policy changes and other elements? What information is
reliable enough to work with, even if not well proven in
multiple settings? What sorts of political pressures would
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Example: the upcoming US investment in comparative
effectiveness research
The example of comparative effectiveness could illus-
trate how to develop a methodology for mixed methods
of reform. The US Congress appropriated about $10
billion for start-up and $500 million per year (from a fee
assessed on health insurance) for this rather imprecisely
deﬁned work. The shortcomings that motivated this
commitment centred on the recognition that much of
medical research is not readily applicable to the usual
situations of patients, for a number of reasons, and that
deliberately expanding research to broader populations
and to speciﬁed subsets could provide more authorita-
tive answers to treatment questions that doctors and
patients actually face. In some instances, this
only requires repeating randomised clinical trials in
broader populations to test whether effects documented
in narrowly deﬁned populations still are evident in more
typical populations. However, half of the topics in
the Institute of Medicine (IOM) list require attention to
‘system’ factors,
4 meaning that the way that the delivery
system operates is a key component affecting potential
effectiveness.
For example, the third topic in the IOM priority list is
‘falls,’ which are a particular plague for older people.
Speciﬁcally, the IOM Committee called for research to
‘Compare the effectiveness of primary prevention
methods, such as exercise and balance training, versus
clinical treatments in preventing falls in older adults at
varying degrees of risk.’ Some of the issues in reducing
the impact of falls are amenable to conventional clinical
trials of a manageable size: for example, optimal treat-
ment for reversible postural hypotension or optimal
rehabilitation following elective hip replacement.
However, reducing the impact of falls in a community
will depend heavily upon ‘clinical treatments’ that rely
upon local factors such as the ability to make home
settings safer, the availability and services of monitoring
agencies, and the supportive homemaker and rehabili-
tation services of the local Medicaid beneﬁt. Indeed,
perhaps the most important factor will be the prioriti-
sation of mitigating this problem in many parts of the
social system, from housing to transportation as well as
healthcare services.
Thus, in devising a strategy to learn what we need to
know in order to address the problem of falls, those who
allocate funds and shape initiatives will need to develop
a balanced strategy that tests medical treatments in
broad populations and subsetsdand that also tests the
merits of various ways of forging the will to address the
problem (generating motivating data and organising
advocates, for example) and of various ways of managing
a process of change (technical assistance, coalition-
building and ﬁnancial incentives, for example). The
point would be to generate, within a reasonably short
time, a substantially growing expertise in how to prevent
and mitigate harm from fallsdaddressing, for example,
individual clinicians and their patients, leaders of insti-
tutions providing services, public health ofﬁcials,
contributing social service and public infrastructure
entities, and working groups focused upon a geographical
locale. The products might include speciﬁc interactive
models to assist physicians in decision-making about
medication combinations and side effects, as well as
speciﬁc recommendations on lighting, doorways and
bathroom ﬁxtures in new housing. In the USA, these
opportunities rest not only in the comparative effec-
tiveness initiative but also in the new funding and
programmes for Accountable Care Organisations,
Medical Homes, Health Homes, Dual Eligibles (beneﬁ-
ciaries with both Medicaid and Medicare) and Commu-
nity-Based Care Transitions. I am sure that similar
opportunities can be found in many other countries.
FIRST STEPS FOR THE IMPROVEMENT SCIENCE FIELD
Achieving important aims will require vision, leadership
and rapid learning. What could work? Those now
focused on organisational management and improve-
ment activities will need to learn to address the health
of populations, since most clinical priorities require
working across an array of delivery system boundaries
in order to beneﬁt a population efﬁciently. The popu-
lation of interest may well mostly be local, since sick
and disabled people tend to have to use services within
reach. Of course, we must also discern how to forge the
will that will cause leadership to care to beneﬁt the
communitydand in the USA, to learn how to stretch
the limits of community-focused action by multiple
self-interested businesses with no local governance.
Organising for responsible advocacy
We also need to learn how to keep, at least those involved
in quality improvement, abreast of initiatives arising from
healthcare reforms and how to enable us to take action to
inform and shape these endeavours. For example, the
US Assistant Secretary for Planning and Evaluation
has recently asked the public for suggestions as to
how to build an inventory of comparative effectiveness
research
5; quality improvement insights need to show up
in such an inventory. The US Internal Revenue Service
recentlyaskedforcommentastohownon-proﬁthospitals
should have to use their community beneﬁt funds
6;
quality improvement interests should have put their
point of view. The PPACA
1 established a Patient-Centred
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a Methodology Committee on comparative effectiveness
research; the insights from quality improvement activities
needtobepartofthatwork.Theopportunitiesarelegion,
but people involved in improved management of health-
care services delivery have no mature organisations moni-
toring and coordinating responses to these opportunities.
Some older issues will take on renewed importance in
the months ahead. The persistently ambiguous scope of
application of the US regulations concerning protection
of human subjects in research will need to be revisited
and clariﬁed. The mandates of the National Institutes of
Health, which mostly restrict their funding to general-
isable research on prevention and cure, may need to be
examined and revised to allow their participation in
developing methods to draw insights from context-
sensitive improvement work. US antitrust law raises new
challenges for initiatives that focus upon local popula-
tions and require broad cooperation to succeed. Even
copyright and trademark issues have a new layer of
complications when multiple parties working in the
public interest generate an instrument or protocol
worthy of marketing to other localities. Having scholars
and managers ready to handle these issues would position
the ﬁeld of improvement science well.
Some may believe that these issues have less urgency
now that Dr Don Berwick is head of the Centers for
Medicare and Medicaid Services in the USA. Dr Berwick
has been a motivating force and guiding light for quality
improvement, and some will think that he can lead the
changes we need. However, Dr Berwick cannot do much
on his own. Advocates are going to need to be devel-
oping insights, political strategies and action plans that
make it possible for him to lead. In any reasonably
democratic society, leaders cannot be much ahead of the
ﬂockdso people concerned for system performance
improvement and other methods are going to need to
move ahead briskly in order make it safe enough for Dr
Berwick and political leaders in Congress and state
legislatures to capitalise on the opportunities, rather
than retreating to established patterns that accept delay
and resist reform.
People interested in evidence-based improvement can
ﬁnd various strategies to gain the experience to have an
effective voice in the current health reform efforts, but
we do need to undertake to do them quickly. The
Academy for Healthcare Improvement could take on an
informing and coordinating function, including atten-
tion to a number of countries where its membership is
active. The Institute for Healthcare Improvement could
expand its scope to help around the world with moni-
toring, brainstorming and building consensus. Indi-
vidual leaders and allied professional and trade
organisations could invest in skills and contacts needed
to participate effectively.
Conclusion
The time is upon us, and it may be a long time returning
if the current opportunities end up doing the same old
things and replicating the same familiar shortcomings.
In policy, as in life generally, the time-honoured apho-
rism holds: ‘If we keep doing what we’ve been doing,
we’ll keep getting what we’ve been getting.’ Now is a very
auspicious time to start doing things differently with
regard to developing a methodology sufﬁcient to guide
healthcare services delivery reform with conﬁdence and
efﬁciency.
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